» Articles » PMID: 6180183

Evidence for Two Classes of Chromatin-associated Epstein-Barr Virus-determined Nuclear Antigen

Overview
Journal J Virol
Date 1982 Aug 1
PMID 6180183
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A new class of Epstein-Barr virus nuclear antigen (EBNA) was identified by the complement fixation assay. This new species of EBNA is more tightly bound to chromatin and was termed class II EBNA, as opposed to the more weakly associated species, class I EBNA. Preparations of this new antigen(s) specifically reduced absorption with the titer of anti-EBNA antibodies as determined by the anticomplement immunofluorescence assay. Therefore, the complement fixation antigens (class II EBNA) appear to be related to the classical EBNA (class I EBNA). The class I EBNA was found to focus at the same pH (4.6) as the soluble antigen found in the cytosol. The class II EBNA differed from the class I EBNA with regard to its overall charge, molecular size, antigenicity, and affinity for chromatin. The class II EBNA appeared to be a basic protein, based on its apparent pI of 9.2 and its binding to cation-exchange resins. It differed from histones with regard to its molecular size (molecular weight between 60,000 and 70,000) and its elution from hydroxylapatite chromatography. Steps were taken to prevent proteolysis and artifacts in the immunological assays and in the overall charge estimation of the new antigen by nonspecific basic histone protein-acidic protein interactions. Both class I and class II EBNA were identified by radioimmunoelectrophoresis on two-dimensional polyacrylamide gels with pI values of 5.0 and 8.5, respectively, and a molecular weight range of 60,000 to 70,000 for both. A lower-molecular-weight antigen identified by molecular sieve chromatography appeared to be due to interference by histones in the immunoassays since it was not observed by the two-dimensional gel electrophoresis. Further characterization of this class II EBNA is in progress.

Citing Articles

Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

Grogan E, Summers W, Dowling S, Shedd D, Gradoville L, Miller G Proc Natl Acad Sci U S A. 1983; 80(24):7650-3.

PMID: 6324183 PMC: 534398. DOI: 10.1073/pnas.80.24.7650.


Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Fischer D, Robert M, Shedd D, Summers W, Robinson J, Wolak J Proc Natl Acad Sci U S A. 1984; 81(1):43-7.

PMID: 6320171 PMC: 344606. DOI: 10.1073/pnas.81.1.43.


Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.

Billings P, Hoch S, White P, Carson D, Vaughan J Proc Natl Acad Sci U S A. 1983; 80(23):7104-8.

PMID: 6316343 PMC: 390001. DOI: 10.1073/pnas.80.23.7104.


One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

Hennessy K, Kieff E Proc Natl Acad Sci U S A. 1983; 80(18):5665-9.

PMID: 6310587 PMC: 384319. DOI: 10.1073/pnas.80.18.5665.


Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen.

Luka J, Kreofsky T, Pearson G, Hennessy K, Kieff E J Virol. 1984; 52(3):833-8.

PMID: 6208381 PMC: 254603. DOI: 10.1128/JVI.52.3.833-838.1984.


References
1.
Mancini G, Carbonara A, Heremans J . Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965; 2(3):235-54. DOI: 10.1016/0019-2791(65)90004-2. View

2.
Epstein M, ACHONG B, BARR Y, Zajac B, Henle G, Henle W . Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst. 1966; 37(4):547-59. View

3.
Bramhall S, Noack N, Wu M, Loewenberg J . A simple colorimetric method for determination of protein. Anal Biochem. 1969; 31(1):146-8. DOI: 10.1016/0003-2697(69)90251-6. View

4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

5.
DURR F, MONROE J, Schmitter R, Traul K, Hirshaut Y . Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells. Int J Cancer. 1970; 6(3):436-49. DOI: 10.1002/ijc.2910060315. View